Terug
51
Dagbereik
€ 155,67
€ 158,10
52-Weeksbereik
€ 127,59
€ 187,35
Volume
1.652.406
50D / 200D Gem.
€ 166,77
/
€ 151,59
Vorige Slotkoers
€ 154,13
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 33,7 | 0,4 |
| P/B | 2,2 | 2,9 |
| ROE % | 6,5 | 3,8 |
| Net Margin % | 7,7 | 3,9 |
| Rev Growth 5Y % | 3,4 | 10,0 |
| D/E | 0,8 | 0,2 |
Koersdoel Analisten
Hold
€ 193,80
+24.0%
Low: € 170,00
High: € 215,00
Forward K/W
12,5
Forward WPA
€ 12,52
WPA Groei (sch.)
+0,0%
Omzet Sch.
19 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 16,91
€ 16,75 – € 17,26
|
22 B | 1 |
| FY2029 |
€ 15,63
€ 15,48 – € 15,95
|
21 B | 1 |
| FY2028 |
€ 14,29
€ 14,16 – € 14,59
|
20 B | 1 |
Belangrijkste Punten
Revenue grew 3,37% annually over 5 years — modest growth
Generating 2,67B in free cash flow
P/E of 33,73 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4,86%
Cash machine — converts 159,12% of earnings into free cash flow
Capital efficient — spends only 3,48% of revenue on capex
Groei
Revenue Growth (5Y)
3,37%
Revenue (1Y)8,23%
Earnings (1Y)-1,58%
FCF Growth (3Y)12,36%
Kwaliteit
Return on Equity
6,54%
ROIC4,34%
Net Margin7,68%
Op. Margin11,80%
Veiligheid
Debt / Equity
0,76
Current Ratio1,11
Interest Coverage4,21
Waardering
P/E Ratio
33,73
P/B Ratio2,23
EV/EBITDA29,07
Dividend Yield0,04%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 8,23% | Revenue Growth (3Y) | 6,18% |
| Earnings Growth (1Y) | -1,58% | Earnings Growth (3Y) | 6,34% |
| Revenue Growth (5Y) | 3,37% | Earnings Growth (5Y) | -5,36% |
| Profitability | |||
| Revenue (TTM) | 21,84B | Net Income (TTM) | 1,68B |
| ROE | 6,54% | ROA | 3,03% |
| Gross Margin | 45,44% | Operating Margin | 11,80% |
| Net Margin | 7,68% | Free Cash Flow (TTM) | 2,67B |
| ROIC | 4,34% | FCF Growth (3Y) | 12,36% |
| Safety | |||
| Debt / Equity | 0,76 | Current Ratio | 1,11 |
| Interest Coverage | 4,21 | Dividend Yield | 0,04% |
| Valuation | |||
| P/E Ratio | 33,73 | P/B Ratio | 2,23 |
| P/S Ratio | 2,59 | PEG Ratio | -29,05 |
| EV/EBITDA | 29,07 | Dividend Yield | 0,04% |
| Market Cap | 56,60B | Enterprise Value | 74,93B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 21,84B | 20,18B | 19,37B | 18,87B | 19,13B |
| Net Income | 1,68B | 1,71B | 1,48B | 1,78B | 2,09B |
| EPS (Diluted) | 5,83 | 5,86 | 4,94 | 5,88 | 6,85 |
| Gross Profit | 9,92B | 9,13B | 8,17B | 8,48B | 8,63B |
| Operating Income | 2,58B | 2,40B | 2,11B | 2,28B | 2,25B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 55,33B | 57,29B | 52,78B | 52,93B | 53,88B |
| Total Liabilities | 29,94B | 31,40B | 26,98B | 27,65B | 30,20B |
| Shareholders' Equity | 25,39B | 25,89B | 25,80B | 25,28B | 23,68B |
| Total Debt | 19,18B | 21,59B | 16,82B | 16,95B | 18,42B |
| Cash & Equivalents | 851,00M | 1,86B | 1,42B | 1,16B | 2,39B |
| Current Assets | 9,26B | 10,47B | 8,68B | 8,14B | 8,84B |
| Current Liabilities | 8,31B | 8,96B | 6,64B | 7,81B | 6,63B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#373 of 1024
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026